Overall, compelling evidence points to a potential role of HOTAIR as a biomarker for CRC prediction and diagnosis, due to its detection in bodily fluids [99,100], prognosis [101], and as a potential therapeutic target for the development of novel strategies to target its overexpression [94,98]. This evidence concerns the gene HOTAIR and colorectal carcinoma.